BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15992375)

  • 1. Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity.
    Zagol-Ikapitte I; Masterson TS; Amarnath V; Montine TJ; Andreasson KI; Boutaud O; Oates JA
    J Neurochem; 2005 Aug; 94(4):1140-5. PubMed ID: 15992375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway.
    Boutaud O; Brame CJ; Salomon RG; Roberts LJ; Oates JA
    Biochemistry; 1999 Jul; 38(29):9389-96. PubMed ID: 10413514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of bis(levuglandinyl) urea derivatives as products of the reaction between prostaglandin H2 and arginine.
    Zagol-Ikapitte I; Bernoud-Hubac N; Amarnath V; Roberts LJ; Boutaud O; Oates JA
    Biochemistry; 2004 May; 43(18):5503-10. PubMed ID: 15122916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation.
    Boutaud O; Li J; Zagol I; Shipp EA; Davies SS; Roberts LJ; Oates JA
    J Biol Chem; 2003 May; 278(19):16926-8. PubMed ID: 12637576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of chronic oxidative and inflammatory stress by quantification of isoketal/levuglandin gamma-ketoaldehyde protein adducts using liquid chromatography tandem mass spectrometry.
    Davies SS; Amarnath V; Brame CJ; Boutaud O; Roberts LJ
    Nat Protoc; 2007; 2(9):2079-91. PubMed ID: 17853863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-dependent lipid-modification of brain proteins.
    Boutaud O; Andreasson KI; Zagol-Ikapitte I; Oates JA
    Brain Pathol; 2005 Apr; 15(2):139-42. PubMed ID: 15912886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
    Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular pathology in Alzheimer's disease].
    Coria Balanzat F
    Med Clin (Barc); 1988 May; 90(18):739-42. PubMed ID: 3172872
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of covalent adducts of nucleosides and DNA formed by reaction with levuglandin.
    Carrier EJ; Amarnath V; Oates JA; Boutaud O
    Biochemistry; 2009 Nov; 48(45):10775-81. PubMed ID: 19824699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1-42 oligomers.
    Boutaud O; Ou JJ; Chaurand P; Caprioli RM; Montine TJ; Oates JA
    J Neurochem; 2002 Aug; 82(4):1003-6. PubMed ID: 12358806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of platelet activation in Alzheimer's disease.
    Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
    Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD; Ermak G; Davies KJ
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.
    Sultana R; Poon HF; Cai J; Pierce WM; Merchant M; Klein JB; Markesbery WR; Butterfield DA
    Neurobiol Dis; 2006 Apr; 22(1):76-87. PubMed ID: 16378731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-Oestradiol stimulation of G-proteins in aged and Alzheimer's human brain: comparison with phytoestrogens.
    Jefremov V; Rakitin A; Mahlapuu R; Zilmer K; Bogdanovic N; Zilmer M; Karelson E
    J Neuroendocrinol; 2008 May; 20(5):587-96. PubMed ID: 18363809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.
    Boutaud O; Brame CJ; Chaurand P; Li J; Rowlinson SW; Crews BC; Ji C; Marnett LJ; Caprioli RM; Roberts LJ; Oates JA
    Biochemistry; 2001 Jun; 40(23):6948-55. PubMed ID: 11389610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
    Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
    Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurochemistry in Alzheimer's disease].
    Hariguchi S
    Seishin Shinkeigaku Zasshi; 1987; 89(9):669-79. PubMed ID: 2894694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.